| Year |
Title |
Altmetric |
| 2023
|
HIV post-treatment controllers have distinct immunological and virological features
2023
|
|
| 2023
|
Validity Properties of a Self-reported Modified Frailty Phenotype Among People With HIV in Clinical Care in the United States.
Journal of the Association of Nurses in AIDS Care.
34:158-170.
2023
|
|
| 2023
|
Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
HIV Medicine.
2023
|
|
| 2022
|
Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
Drug and Alcohol Dependence.
241.
2022
|
|
| 2022
|
Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatment.
Drug and Alcohol Dependence.
240.
2022
|
|
| 2022
|
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.
EClinicalMedicine.
53.
2022
|
|
| 2022
|
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort.
HIV Medicine.
23:1051-1060.
2022
|
|
| 2022
|
Factors Associated with Severity of COVID-19 Disease in a Multicenter Cohort of People with HIV in the United States, March-December 2020
2022
|
|
| 2022
|
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.
AIDS.
36:1095-1103.
2022
|
|
| 2022
|
Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science..
Physiological Reviews.
102:1569-1577.
2022
|
|
| 2022
|
HIV Symptom Clusters are Similar Using the Dimensions of Symptom Occurrence and Distress.
Journal of Pain and Symptom Management.
63:943-952.
2022
|
|
| 2022
|
Insomnia and Risk of Myocardial Infarction Among People With HIV
2022
|
|
| 2022
|
Risk factors for atrial fibrillation in a multicenter United States clinical cohort of people with HIV infection.
AIDS.
36:903-905.
2022
|
|
| 2022
|
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?.
AIDS.
36:657-664.
2022
|
|
| 2022
|
Safer in care: A pandemic-tested model of integrated HIV/OUD care.
Drug and Alcohol Dependence.
231.
2022
|
|
| 2021
|
Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US.
2021
|
|
| 2021
|
A 12-year retrospective evaluation of anal pre-cancerous lesions and cancer in people living with HIV-1 infection in the Southeastern U.S.
Infectious Agents and Cancer.
16.
2021
|
|
| 2021
|
Correction to: Genetic architecture of cardiometabolic risks in people living with HIV (BMC Medicine, (2020), 18, 1, (288), 10.1186/s12916-020-01762-z).
BMC Medicine.
19.
2021
|
|
| 2021
|
Decreased Alcohol Consumption in an Implementation Study of Computerized Brief Intervention among HIV Patients in Clinical Care.
AIDS and Behavior.
25:4074-4084.
2021
|
|
| 2021
|
Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020.
2021
|
|
| 2021
|
The impact of COVID-19 on mentoring early-career investigators: "Everything can wait. Listen more than usual and share your own struggles".
Medicine.
100:E27423.
2021
|
|
| 2021
|
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.
Clinical Infectious Diseases.
73:E2334-E2337.
2021
|
|
| 2021
|
Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
Clinical Infectious Diseases.
73:E2234-E2242.
2021
|
|
| 2021
|
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study..
ACP journal club.
174:1197-1206.
2021
|
|
| 2021
|
Predictors of Nonseroconversion after SARS-CoV-2 Infection
2021
|
|
| 2021
|
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans with HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study
2021
|
|
| 2021
|
Current and Past Immunodeficiency Are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years.
Journal of Infectious Diseases.
224:657-666.
2021
|
|
| 2021
|
Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV.
Journal of Investigative Medicine.
69:1238-1244.
2021
|
|
| 2021
|
Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study.
Medicine.
100:E26588.
2021
|
|
| 2021
|
Hospitalization Rates and Causes among Persons with HIV in the United States and Canada, 2005-2015.
Journal of Infectious Diseases.
223:2113-2123.
2021
|
|
| 2021
|
HIV Infection - Screening, Diagnosis, and Treatment..
New England Journal of Medicine.
384:2131-2143.
2021
|
|
| 2021
|
Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with Human Immunodeficiency Virus.
Clinical Infectious Diseases.
72:1900-1909.
2021
|
|
| 2021
|
Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America
2021
|
|
| 2021
|
Types of Stroke among People Living with HIV in the United States
2021
|
|
| 2021
|
Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era
2021
|
|
| 2021
|
Drug and alcohol use among people living with HIV in care in the United States by geographic region
2021
|
|
| 2021
|
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.
Science Translational Medicine.
13.
2021
|
|
| 2020
|
Genetic architecture of cardiometabolic risks in people living with HIV.
BMC Medicine.
18.
2020
|
|
| 2020
|
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies.
iScience.
23.
2020
|
|
| 2020
|
Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options.
AIDS.
34:2051-2059.
2020
|
|
| 2020
|
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
Journal of the American Medical Association.
324:1651-1669.
2020
|
|
| 2020
|
Hepatitis C among high-risk alabamians: Disease burden and screening effectiveness.
Journal of Infectious Diseases.
222:S365-S375.
2020
|
|
| 2020
|
What's All This Fuss I Hear About Viral "Blips"?.
Clinical Infectious Diseases.
70:2710-2711.
2020
|
|
| 2020
|
Association between chronic Hepatitis C virus infection and myocardial infarction among people living with HIV in the United States.
American Journal of Epidemiology.
189:554-563.
2020
|
|
| 2020
|
The PROSPER-HIV Study: A Research Protocol to Examine Relationships Among Physical Activity, Diet Intake, and Symptoms in Adults Living With HIV.
Journal of the Association of Nurses in AIDS Care.
31:346-352.
2020
|
|
| 2020
|
Z boson production in Pb+Pb collisions at √Snn = 5.02 TeV measured by the ATLAS experiment
2020
|
|
| 2020
|
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia with Anal Cancer Risk in Persons Living with HIV in the United States and Canada.
Clinical Infectious Diseases.
70:1176-1185.
2020
|
|
| 2020
|
Impact of abstinence and of reducing illicit drug use without abstinence on human immunodeficiency virus viral load.
Clinical Infectious Diseases.
70:867-874.
2020
|
|
| 2020
|
Measurement of differential cross sections for single diffractive dissociation in √s = 8 TeV pp collisions using the ATLAS ALFA spectrometer
2020
|
|
| 2020
|
Precision measurement of the Ξcc++ mass
2020
|
|
| 2020
|
Search for electroweak production of charginos and sleptons decaying into final states with two leptons and missing transverse momentum in √s=13 TeV pp collisions using the ATLAS detector
2020
|
|
| 2020
|
Search for the doubly charmed baryon Ξcc+.
SCIENCE CHINA Physics, Mechanics and Astronomy.
63.
2020
|
|
| 2020
|
Search for A →μ+μ-Decays.
Physical Review Letters.
124.
2020
|
|
| 2020
|
Search for Magnetic Monopoles and Stable High-Electric-Charge Objects in 13 Tev Proton-Proton Collisions with the ATLAS Detector.
Physical Review Letters.
124.
2020
|
|
| 2020
|
Amplitude analysis of the B+ →π+π+π- decay.
Physical Review D.
101.
2020
|
|
| 2020
|
Observation of Several Sources of CP Violation in B+ →π+π+π- Decays.
Physical Review Letters.
124.
2020
|
|
| 2020
|
Updated measurement of decay-time-dependent CP asymmetries in D0 →k+K- A nd D0 →π+π-decays.
Physical Review D.
101.
2020
|
|
| 2020
|
Combined measurements of Higgs boson production and decay using up to 80 fb-1 of proton-proton collision data at √s =13 TeV collected with the ATLAS experiment.
Physical Review D.
101.
2020
|
|
| 2020
|
Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia.
PLoS One.
15.
2020
|
|
| 2020
|
Erratum to: Measurement of ψ(2 S) meson production in pp collisions at s = 7 TeV (The European Physical Journal C, (2012), 72, 8, (2100), 10.1140/epjc/s10052-012-2100-4)
2020
|
|
| 2020
|
Measurement of J/ψ production in association with a W ± boson with pp data at 8 TeV
2020
|
|
| 2020
|
Measurement of long-range two-particle azimuthal correlations in Z-boson tagged pp collisions at √s=8 and 13 TeV
2020
|
|
| 2020
|
Obesity Affects the Association of Bioelectrical Impedance Phase Angle With Mortality in People Living With HIV.
Journal of the Association of Nurses in AIDS Care.
31:51-59.
2020
|
|
| 2020
|
Performance of electron and photon triggers in ATLAS during LHC Run 2
2020
|
|
| 2020
|
Transverse momentum and process dependent azimuthal anisotropies in √sNN=8.16 TeV p+Pb collisions with the ATLAS detector
2020
|
|
| 2019
|
Measurement of the Bc− meson production fraction and asymmetry in 7 and 13 TeV pp collisions.
Physical Review D.
100.
2019
|
|
| 2019
|
Search for Lepton-Flavor Violating Decays B+ →k+μ±eâ".
Physical Review Letters.
123.
2019
|
|
| 2019
|
Electron and photon performance measurements with the ATLAS detector using the 2015-2017 LHC proton-proton collision data.
Journal of Instrumentation.
14.
2019
|
|
| 2019
|
Amplitude Analysis of B± →π±K+K- Decays.
Physical Review Letters.
123.
2019
|
|
| 2019
|
Measurement of Charged Hadron Production in Z -Tagged Jets in Proton-Proton Collisions at s =8 TeV.
Physical Review Letters.
123.
2019
|
|
| 2019
|
Measurement of CP violation in the Bs0→ϕϕ decay and search for the B 0 → ϕϕ decay
2019
|
|
| 2019
|
Measurement of KS0 and Λ production in tt¯ dileptonic events in pp collisions at √s= 7 TeV with the ATLAS detector
2019
|
|
| 2019
|
Measurement of flow harmonics correlations with mean transverse momentum in lead–lead and proton–lead collisions at √sNN=5.02TeV with the ATLAS detector
2019
|
|
| 2019
|
Measurements of top-quark pair differential and double-differential cross-sections in the ℓ +jets channel with pp collisions at √s=13 TeV using the ATLAS detector
2019
|
|
| 2019
|
Search for bottom-squark pair production with the ATLAS detector in final states containing Higgs bosons, b-jets and missing transverse momentum
2019
|
|
| 2019
|
Search for the Lepton-Flavor-Violating Decays Bs0 →τ±μâ" and B0 →τ±μâ".
Physical Review Letters.
123.
2019
|
|
| 2019
|
Case 36-2019: A 34-Year-Old Man with Dyspnea, Odynophagia, and Abdominal Pain..
New England Journal of Medicine.
381:2052-2061.
2019
|
|
| 2019
|
Search for a right-handed gauge boson decaying into a high-momentum heavy neutrino and a charged lepton in pp collisions with the ATLAS detector at s=13 TeV
2019
|
|
| 2019
|
Déjà vu all over again..
AIDS.
33:2097-2098.
2019
|
|
| 2019
|
Observation of New Resonances in the Λb0 π+π- System.
Physical Review Letters.
123.
2019
|
|
| 2019
|
Measurement of the CP-violating phase ϕs from Bs0→J/ψπ+π− decays in 13 TeV pp collisions
2019
|
|
| 2019
|
A search for Ξcc++ → D+pK− π + decays
2019
|
|
| 2019
|
Identification of boosted Higgs bosons decaying into b-quark pairs with the ATLAS detector at 13 TeV
2019
|
|
| 2019
|
Measurement of fiducial and differential W+W- production cross-sections at √s=13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Measurement of the inclusive cross-section for the production of jets in association with a Z boson in proton–proton collisions at 8 TeV using the ATLAS detector
2019
|
|
| 2019
|
Measurement of the inclusive isolated-photon cross section in pp collisions at √s = 13 TeV using 36 fb−1 of ATLAS data
2019
|
|
| 2019
|
Search for a heavy charged boson in events with a charged lepton and missing transverse momentum from pp collisions at s =13 TeV with the ATLAS detector.
Physical Review D.
100.
2019
|
|
| 2019
|
Properties of jet fragmentation using charged particles measured with the ATLAS detector in pp collisions at s =13 TeV.
Physical Review D.
100.
2019
|
|
| 2019
|
Resolution of the ATLAS muon spectrometer monitored drift tubes in LHC Run 2.
Journal of Instrumentation.
14.
2019
|
|
| 2019
|
Search for high-mass dilepton resonances using 139 fb−1 of pp collision data collected at √s=13 TeV with the ATLAS detector
2019
|
|
| 2019
|
HIV 101: fundamentals of antiretroviral therapy..
Topics in antiviral medicine.
27:123-127.
2019
|
|
| 2019
|
Observation of the Λb0→χc1 (3872) pK− decay
2019
|
|
| 2019
|
Measurement of b hadron fractions in 13 TeV pp collisions.
Physical Review D.
100.
2019
|
|
| 2019
|
Measurement of CP -Violating and Mixing-Induced Observables in Bs0 →φγ Decays.
Physical Review Letters.
123.
2019
|
|
| 2019
|
Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.
2019
|
|
| 2019
|
Virologic Failure Among People Living With HIV Initiating Dolutegravir-Based Versus Other Recommended Regimens in Real-World Clinical Care Settings
2019
|
|
| 2019
|
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
AIDS Research and Human Retroviruses.
35:691-697.
2019
|
|
| 2019
|
Erratum: Search for supersymmetry in final states with two same-sign or three leptons and jets using 36 fb−1 of s = 13 TeV pp collision data with the ATLAS detector (Journal of High Energy Physics, (2017), 2017, 9, (84), 10.1007/JHEP09(2017)084)
2019
|
|
| 2019
|
Measurement of CP observables in the process B 0 → DK *0 with two- and four-body D decays
2019
|
|
| 2019
|
Measurement of distributions sensitive to the underlying event in inclusive Z boson production in pp collisions at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Measurement of jet-substructure observables in top quark, W boson and light jet production in proton-proton collisions at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Precision measurement of the Λc+, Ξc+, and Ξc0 baryon lifetimes.
Physical Review D.
100.
2019
|
|
| 2019
|
Search for the rare decay B+→μ+μ-μ+νμ
2019
|
|
| 2019
|
Updated measurement of time-dependent CP -violating observables in Bs0→J/ψK+K- decays
2019
|
|
| 2019
|
Mortality following myocardial infarction among HIV-infected persons: The Center for AIDS Research Network of Integrated Clinical Systems (CNICS).
BMC Medicine.
17.
2019
|
|
| 2019
|
Search for chargino and neutralino production in final states with a Higgs boson and missing transverse momentum at s =13 TeV with the ATLAS detector.
Physical Review D.
100.
2019
|
|
| 2019
|
Comparison of Fragmentation Functions for Jets Dominated by Light Quarks and Gluons from pp and Pb+Pb Collisions in ATLAS.
Physical Review Letters.
123.
2019
|
|
| 2019
|
First Observation of the Radiative Decay Λb0 → Λγ.
Physical Review Letters.
123.
2019
|
|
| 2019
|
Amplitude analysis of the B(s)0→K∗0K¯∗0 decays and measurement of the branching fraction of the B→ K∗ 0K¯ ∗ 0 decay
2019
|
|
| 2019
|
Near-threshold $$ \mathrm{D}\overline{\mathrm{D}} $$ spectroscopy and observation of a new charmonium state
2019
|
|
| 2019
|
Search for scalar resonances decaying into μ + μ − in events with and without b-tagged jets produced in proton-proton collisions at √s=13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Alcohol Use Patterns and Subsequent Sexual Behaviors Among Women, Men who have Sex with Men and Men who have Sex with Women Engaged in Routine HIV Care in the United States.
AIDS and Behavior.
23:1634-1646.
2019
|
|
| 2019
|
Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.
Statistics in Medicine.
38:2428-2446.
2019
|
|
| 2019
|
Measurement of the Mass Difference between Neutral Charm-Meson Eigenstates.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Combination of Searches for Invisible Higgs Boson Decays with the ATLAS Experiment.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Observation of an Excited Bc+ State.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Search for invisible Higgs boson decays in vector boson fusion at s=13TeV with the ATLAS detector
2019
|
|
| 2019
|
Observation of a Narrow Pentaquark State, Pc (4312)+, and of the Two-Peak Structure of the Pc (4450)+.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Amplitude analysis of Bs0 → KS0 K ± π ∓ decays
2019
|
|
| 2019
|
Marijuana Use Is Not Associated with Changes in Opioid Prescriptions or Pain Severity among People Living with HIV and Chronic Pain
2019
|
|
| 2019
|
Measurement of the branching fraction and CP asymmetry in B+→J/ψρ+ decays
2019
|
|
| 2019
|
Observation of CP Violation in Charm Decays.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Search for top-quark decays t → Hq with 36 fb−1 of pp collision data at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Observation of B (s)0 →j/ψp p Decays and Precision Measurements of the B (s)0 Masses.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Search for CP Violation in Ds+ → K0Sπ+, D+ → K0SK+, and D+ → ϕπ+ Decays.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Search for Lepton-Universality Violation in B+ → K+l+l- Decays.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Associations of food insecurity and psychosocial measures with diet quality in adults aging with HIV
2019
|
|
| 2019
|
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART
2019
|
|
| 2019
|
Erratum to: Measurements of W and Z boson production in pp collisions at s = 5.02 TeV with the ATLAS detector (The European Physical Journal C, (2019), 79, 2, (128), 10.1140/epjc/s10052-019-6622-x)
2019
|
|
| 2019
|
Measurement of VH, H → b b ¯ production as a function of the vector-boson transverse momentum in 13 TeV pp collisions with the ATLAS detector
2019
|
|
| 2019
|
Measurement of the relative B- →d0 /D∗0 /D∗∗0μ- ν μ branching fractions using B- mesons from B s2∗0 decays.
Physical Review D.
99.
2019
|
|
| 2019
|
Measurements of inclusive and differential fiducial cross-sections of tt¯ γ production in leptonic final states at √s=13TeV in ATLAS
2019
|
|
| 2019
|
Performance of top-quark and W -boson tagging with ATLAS in Run 2 of the LHC
2019
|
|
| 2019
|
Search for Higgs boson pair production in the WW(*)WW(*) decay channel using ATLAS data recorded at √s = 13 TeV
2019
|
|
| 2019
|
Search for large missing transverse momentum in association with one top-quark in proton-proton collisions at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Search for single production of vector-like quarks decaying into Wb in pp collisions at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Design and performance of the LHCb trigger and full real-time reconstruction in Run 2 of the LHC.
Journal of Instrumentation.
14.
2019
|
|
| 2019
|
Model-Independent Observation of Exotic Contributions to B0 →j /ψK+π- Decays.
Physical Review Letters.
122.
2019
|
|
| 2019
|
HIV Viral Suppression Trends..
ACP journal club.
170:582-583.
2019
|
|
| 2019
|
First Measurement of Charm Production in its Fixed-Target Configuration at the LHC.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
Lancet HIV.
6:e240-e249.
2019
|
|
| 2019
|
Measurement of the four-lepton invariant mass spectrum in 13 TeV proton-proton collisions with the ATLAS detector
2019
|
|
| 2019
|
Measurement of the ratio of cross sections for inclusive isolated-photon production in pp collisions at √s = 13 and 8 TeV with the ATLAS detector
2019
|
|
| 2019
|
Measurement of the top quark mass in the tt¯ → lepton+jets channel from √s=8 TeV ATLAS data and combination with previous results
2019
|
|
| 2019
|
Measurements of inclusive and differential fiducial cross-sections of tt¯ production with additional heavy-flavour jets in proton-proton collisions at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Observation of the doubly Cabibbo-suppressed decay Ξ c+ → pϕ
2019
|
|
| 2019
|
Search for Higgs boson pair production in the bb¯ WW * decay mode at √s = 13 TeV with the ATLAS detector
2019
|
|
| 2019
|
Study of the rare decays of B s0 and B 0 mesons into muon pairs using data collected during 2015 and 2016 with the ATLAS detector
2019
|
|
| 2019
|
Effectiveness of Direct-Acting Antiviral Therapy in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study.
Open Forum Infectious Diseases.
6.
2019
|
|
| 2019
|
Physical Activity Intensity is Associated with Symptom Distress in the CNICS Cohort.
AIDS and Behavior.
23:627-635.
2019
|
|
| 2019
|
A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug Use.
Clinical Infectious Diseases.
68:1041-1043.
2019
|
|
| 2019
|
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals with Sustained Virological Suppression on Antiretroviral Therapy
2019
|
|
| 2019
|
Measurement of B+, B0 and Λb0 production in pPb collisions at sNN =8.16 TeV.
Physical Review D.
99.
2019
|
|
| 2019
|
Measurement of the branching fractions of the decays D + → K − K + K + , D + → π − π + K + and D s+ → π − K + K +
2019
|
|
| 2019
|
Measurement of the mass and production rate of Ξb- baryons.
Physical Review D.
99.
2019
|
|
| 2019
|
Measurement of the ratio of branching fractions of the decays Λ b0 → ψ(2S)Λ and Λ b0 → J/ψΛ
2019
|
|
| 2019
|
Physical functioning among patients aging with Human Immunodeficiency Virus (HIV) Versus HIV uninfected: Feasibility of using the short physical performance battery in clinical care of people living with HIV aged 50 or older.
Open Forum Infectious Diseases.
6.
2019
|
|
| 2019
|
Observation of Two Resonances in the Λb0 π± Systems and Precise Measurement of Σb± and Σb∗± Properties.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Measurement of the Charm-Mixing Parameter yCP.
Physical Review Letters.
122.
2019
|
|
| 2019
|
Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort..
Open Forum Infectious Diseases.
6:ofy273.
2019
|
|
| 2019
|
Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.
Epidemiology.
30:69-74.
2019
|
|
| 2019
|
Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia.
Antiviral Therapy.
24:291-300.
2019
|
|
| 2018
|
Evidence for an ηc(1 S) π- resonance in B0→ ηc(1 S) K+π- decays
2018
|
|
| 2018
|
Global, regional, and national burden of tuberculosis, 1990-2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study.
Lancet Infectious Diseases.
18:1329-1349.
2018
|
|
| 2018
|
Search for lepton-flavour-violating decays of Higgs-like bosons
2018
|
|
| 2018
|
Measurement of Antiproton Production in p-He Collisions at sNN =110 GeV.
Physical Review Letters.
121.
2018
|
|
| 2018
|
Baseline Genotype Testing to Assess Drug Resistance before Beginning HIV Treatment - Reply.
Journal of the American Medical Association.
320:2154.
2018
|
|
| 2018
|
Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.
2018
|
|
| 2018
|
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
AIDS Research and Human Retroviruses.
34:916-921.
2018
|
|
| 2018
|
Study of ϒ production in pPb collisions at √sNN=8.16 TeV
2018
|
|
| 2018
|
HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015 a cohort study.
ACP journal club.
169:376-384.
2018
|
|
| 2018
|
Brief report: The association of chronic pain and long-term opioid therapy with HIV treatment outcomes
2018
|
|
| 2018
|
Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery.
Colorectal Disease.
20:58-68.
2018
|
|
| 2018
|
Safety of primary anastomosis following emergency left sided colorectal resection: an international, multi-centre prospective audit.
Colorectal Disease.
20:47-57.
2018
|
|
| 2018
|
A Randomized Pilot Trial of a Novel Behavioral Intervention for Chronic Pain Tailored to Individuals with HIV.
AIDS and Behavior.
22:2733-2742.
2018
|
|
| 2018
|
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel.
Journal of the American Medical Association.
320:379-396.
2018
|
|
| 2018
|
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio..
AIDS.
32:1361-1367.
2018
|
|
| 2018
|
Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial.
Contemporary Clinical Trials.
69:48-54.
2018
|
|
| 2018
|
Intervention Mapping to develop a Social Cognitive Theory-based intervention for chronic pain tailored to individuals with HIV.
Contemporary Clinical Trials Communications.
10:9-16.
2018
|
|
| 2018
|
Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study..
AIDS.
2018
|
|
| 2018
|
Multimorbidity among Persons Living with Human Immunodeficiency Virus in the United States.
Clinical Infectious Diseases.
66:1230-1238.
2018
|
|
| 2018
|
Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV.
Alcoholism: Clinical and Experimental Research.
42:561-570.
2018
|
|
| 2018
|
Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States.
PLoS One.
13.
2018
|
|
| 2018
|
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
Lancet Infectious Diseases.
18:261-284.
2018
|
|
| 2018
|
Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection.
HIV Medicine.
19:132-142.
2018
|
|
| 2018
|
Trends in antiretroviral therapy prescription, durability and modification: New drugs, more changes, but less failure.
AIDS.
32:347-355.
2018
|
|
| 2018
|
Chronic hepatitis B virus monoinfection at a university hospital in Zambia.
World Journal of Hepatology.
10:622-628.
2018
|
|
| 2018
|
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.
Journal of the International AIDS Society.
21.
2018
|
|
| 2018
|
Point-of-care urine ethyl glucuronide testing to detect alcohol use among HIV-hepatitis B virus coinfected adults in Zambia.
AIDS and Behavior.
22:2334-2339.
2018
|
|
| 2017
|
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial..
Gates Open Research.
1:9.
2017
|
|
| 2017
|
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.
Lancet HIV.
4:e486-e494.
2017
|
|
| 2017
|
CD4:CD8 Ratio and CD8 Count as prognostic markers for mortality in human immunodeficiency virus-infected patients on antiretroviral therapy: The antiretroviral therapy cohort collaboration (ART-CC).
Clinical Infectious Diseases.
65:959-966.
2017
|
|
| 2017
|
In Memorium: William Ernest Dismukes 1939-2017..
Journal of Infectious Diseases.
2017
|
|
| 2017
|
Cancer-Attributable Mortality among People with Treated Human Immunodeficiency Virus Infection in North America.
Clinical Infectious Diseases.
65:636-643.
2017
|
|
| 2017
|
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared with the General Population
2017
|
|
| 2017
|
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
Lancet HIV.
4:e349-e356.
2017
|
|
| 2017
|
Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.
AIDS and Behavior.
21:1914-1925.
2017
|
|
| 2017
|
The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.
AIDS and Behavior.
21:1878-1884.
2017
|
|
| 2017
|
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.
Retrovirology.
14.
2017
|
|
| 2017
|
Associations between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy among Patients Living with HIV.
AIDS Research and Human Retroviruses.
33:534-545.
2017
|
|
| 2017
|
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.
Lancet HIV.
4:e251-e259.
2017
|
|
| 2017
|
Incident AIDS or death after initiation of human immunodeficiency virus treatment regimens including raltegravir or efavirenz among adults in the United States.
Clinical Infectious Diseases.
64:1591-1596.
2017
|
|
| 2017
|
Impact of Antiretroviral Therapy on Liver Fibrosis among Human Immunodeficiency Virus-Infected Adults with and Without HBV Coinfection in Zambia.
Clinical Infectious Diseases.
64:1343-1349.
2017
|
|
| 2017
|
Using Patient Perspectives to Inform the Development of a Behavioral Intervention for Chronic Pain in Patients with HIV: A Qualitative Study.
Pain Medicine.
18:879-888.
2017
|
|
| 2017
|
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.
Medicine.
96.
2017
|
|
| 2017
|
Types of myocardial infarction among human immunodeficiency virus–infected individuals in the United States.
JAMA Cardiology.
2:260-267.
2017
|
|
| 2017
|
TURQUOISE-I part 1b: Ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin for hepatitis C virus infection in HIV-1 coinfected patients on darunavir.
Journal of Infectious Diseases.
215:599-605.
2017
|
|
| 2017
|
Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: A study by the Centers for AIDS Research Network of Integrated Clinical Systems.
JAMA Cardiology.
2:155-162.
2017
|
|
| 2017
|
Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders*
2017
|
|
| 2017
|
Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6))
2017
|
|
| 2017
|
Access to kidney transplantation among HIV-infected waitlist candidates.
Clinical Journal of the American Society of Nephrology.
12:467-475.
2017
|
|
| 2017
|
Brief Report: Factors Associated with the Selection of Initial Antiretroviral Therapy from 2009 to 2012
2017
|
|
| 2017
|
Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities.
Journal of Infectious Diseases.
216:S581-S587.
2017
|
|
| 2016
|
A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and care.
Topics in antiviral medicine.
24:142-151.
2016
|
|
| 2016
|
Using observational data to emulate a randomized trial of dynamic treatmentswitching strategies: An application to antiretroviral therapy.
International Journal of Epidemiology.
45:2038-2049.
2016
|
|
| 2016
|
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
2016
|
|
| 2016
|
A randomized controlled trial protocol to evaluate the effectiveness of an integrated care management approach to improve adherence among HIV-infected patients in routine clinical care: Rationale and design.
JMIR Research Protocols.
5.
2016
|
|
| 2016
|
Characterizing failure to establish hepatitis C care of baby boomers diagnosed in the emergency department.
Open Forum Infectious Diseases.
3.
2016
|
|
| 2016
|
Infection-related and -unrelated malignancies, HIV and the aging population.
HIV Medicine.
17:590-600.
2016
|
|
| 2016
|
Successful re-treatment of hepatitis C virus in patients coinfected with HIV Who relapsed after 12 weeks of ledipasvir/sofosbuvir.
Clinical Infectious Diseases.
63:528-531.
2016
|
|
| 2016
|
Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy.
PLoS One.
11.
2016
|
|
| 2016
|
Poorly controlled HIV infection: An independent risk factor for liver fibrosis
2016
|
|
| 2016
|
Antiretroviral drugs for treatment and prevention of HIV infection in Adults: 2016 recommendations of the international antiviral society-USA Panel.
Journal of the American Medical Association.
316:191-210.
2016
|
|
| 2016
|
Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting.
Drug and Alcohol Dependence.
164:113-119.
2016
|
|
| 2016
|
When to monitor CD4 cell count and HIV RNA to reduce mortality and aids-defining illness in virologically suppressed hiv-positive persons on antiretroviral therapy in high-income countries: A prospective observational study
2016
|
|
| 2016
|
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.
AIDS.
30:1229-1238.
2016
|
|
| 2016
|
HIV primary care providers-Screening, knowledge, attitudes and behaviors related to alcohol interventions.
Drug and Alcohol Dependence.
161:59-66.
2016
|
|
| 2016
|
Implementation of Computer-delivered Brief Alcohol Intervention in HIV Clinical Settings: Who Agrees to Participate?.
Journal of Addiction Research and Therapy.
7.
2016
|
|
| 2016
|
Unanticipated effects of new drug availability on antiretroviral durability: Implications for comparative effectiveness research.
Open Forum Infectious Diseases.
3.
2016
|
|
| 2016
|
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.
AIDS.
30:869-878.
2016
|
|
| 2016
|
Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.
AIDS and Behavior.
20:687-698.
2016
|
|
| 2016
|
Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results from Four HIV Clinics.
Journal of Addiction Medicine.
10:13-19.
2016
|
|
| 2016
|
Cost considerations in the current antiretroviral era.
AIDS.
30:2215-2219.
2016
|
|
| 2016
|
The Silent Epidemic - Frailty and Aging with HIV.
2016
|
|
| 2015
|
Immunization costs and programmatic barriers at an urban HIV clinic.
Clinical Infectious Diseases.
61:1726-1731.
2015
|
|
| 2015
|
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: Consensus recommendations for infection reporting during clinical trials and postmarketing surveillance.
Annals of the Rheumatic Diseases.
74:2107-2116.
2015
|
|
| 2015
|
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
Hepatology.
62:932-954.
2015
|
|
| 2015
|
Obesity is Associated with Race/Sex Disparities in Diabetes and Hypertension Prevalence, but Not Cardiovascular Disease, among HIV-Infected Adults.
AIDS Research and Human Retroviruses.
31:898-904.
2015
|
|
| 2015
|
Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1.
New England Journal of Medicine.
373:705-713.
2015
|
|
| 2015
|
Factors Associated with Missed Psychiatry Visits in an Urban HIV Clinic.
AIDS and Behavior.
19:1423-1429.
2015
|
|
| 2015
|
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial.
Lancet HIV.
2:e319-e327.
2015
|
|
| 2015
|
Editorial Commentary: Getting Smart in How We Pay for HCV Drugs: KAOS vs CONTROL.
Clinical Infectious Diseases.
61:169-170.
2015
|
|
| 2015
|
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial
2015
|
|
| 2015
|
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration
2015
|
|
| 2015
|
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: Two randomised, double-blind, phase 3, non-inferiority trials
2015
|
|
| 2015
|
Quantitative evaluation of an instrument to identify chronic pain in HIV-infected individuals.
AIDS Research and Human Retroviruses.
31:623-627.
2015
|
|
| 2015
|
Short communication: Viral suppression is associated with increased likelihood of colorectal cancer screening among persons living with HIV/AIDS.
AIDS Research and Human Retroviruses.
31:519-524.
2015
|
|
| 2015
|
The RESET project: Constructing a European tephra lattice for refined synchronisation of environmental and archaeological events during the last c. 100 ka
2015
|
|
| 2015
|
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.
2015
|
|
| 2015
|
End-stage renal disease among HIV-infected adults in North America.
Clinical Infectious Diseases.
60:941-949.
2015
|
|
| 2015
|
Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.
Hepatology.
61:776-782.
2015
|
|
| 2015
|
Preventing HIV in women - Still trying to find their voice.
New England Journal of Medicine.
372:564-566.
2015
|
|
| 2015
|
Preventing HIV in women--still trying to find their VOICE.
New England Journal of Medicine.
372:564-566.
2015
|
|
| 2015
|
Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: A randomised controlled trial.
BMC Medicine.
13.
2015
|
|
| 2015
|
Fixing a hole in the HIV safety net.
Clinical Infectious Diseases.
60:126-127.
2015
|
|
| 2015
|
Fructosamine and hemoglobin a1c correlations in HIV-infected adults in routine clinical care: Impact of anemia and albumin levels.
AIDS Research and Treatment.
2015.
2015
|
|
| 2015
|
Stable phenotypic changes of the host T cells are essential to the long-term stability of latent HIV-1 infection.
Journal of Virology.
89:6656-6672.
2015
|
|
| 2015
|
Tenofovir alafenamide versus tenofovir disoproxil fumarate in the first protease inhibitor-based single-tablet regimen for initial HIV-1 therapy: A randomized phase 2 study
2015
|
|
| 2014
|
HIV/AIDS.
Infectious Disease Clinics of North America.
28:9-10.
2014
|
|
| 2014
|
STAR Collaboration.
Nuclear Physics A.
932:634-637.
2014
|
|
| 2014
|
'Two pains together': Patient perspectives on psychological aspects of chronic pain while living with HIV.
PLoS One.
9.
2014
|
|
| 2014
|
Aberrant drug-related behaviors: A qualitative analysis of medical record documentation in patients referred to an HIV/Chronic pain clinic.
Pain Medicine.
15:1724-1733.
2014
|
|
| 2014
|
Enhanced personal contact with HIV patients improves retention in primary care: A randomized trial in 6 US HIV clinics.
Clinical Infectious Diseases.
59:725-734.
2014
|
|
| 2014
|
Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies.
PLoS Medicine.
11.
2014
|
|
| 2014
|
Letters to the editor.
American Journal of Epidemiology.
180:450.
2014
|
|
| 2014
|
Antiretroviral treatment of adult HIV infection: 2014 Recommendations of the International Antiviral Society-USA panel.
Journal of the American Medical Association.
312:410-425.
2014
|
|
| 2014
|
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
Clinical Infectious Diseases.
59:287-297.
2014
|
|
| 2014
|
Decline in locomotor functions over time in HIV-infected patients.
AIDS.
28:1531-1532.
2014
|
|
| 2014
|
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
Clinical Infectious Diseases.
58:1599-1606.
2014
|
|
| 2014
|
Factors associated with delayed hepatitis b viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort
2014
|
|
| 2014
|
Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.
AIDS.
28:979-987.
2014
|
|
| 2014
|
Disparities in the quality of HIV care when using US department of health and human services indicators.
Clinical Infectious Diseases.
58:1185-1189.
2014
|
|
| 2014
|
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.
American Journal of Epidemiology.
179:996-1005.
2014
|
|
| 2014
|
Qualitative investigation of a brief chronic pain screening tool in HIV-infected patients
2014
|
|
| 2014
|
Efficacy and safety of Maraviroc vs. Efavirenz in treatment-naive patients with HIV-1: 5-year findings.
AIDS.
28:717-725.
2014
|
|
| 2014
|
A Conceptual Framework for Understanding Chronic Pain in Patients with HIV.
Pain Practice.
14:207-216.
2014
|
|
| 2014
|
Cohort profile: Antiretroviral therapy cohort collaboration (ART-CC).
International Journal of Epidemiology.
43:691-702.
2014
|
|
| 2014
|
Engagement in human immunodeficiency virus care: Linkage, retention, and antiretroviral therapy adherence.
Infectious Disease Clinics of North America.
28:355-369.
2014
|
|
| 2014
|
Hiv/Aids.
Infectious Disease Clinics of North America.
28.
2014
|
|
| 2014
|
Low Back Pain and Associated Imaging Findings among HIV-Infected Patients Referred to an HIV/Palliative Care Clinic.
Pain Medicine.
15:418-424.
2014
|
|
| 2014
|
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
2014
|
|
| 2013
|
Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care
2013
|
|
| 2013
|
The antiretroviral drug pipeline: Prospects and implications for future treatment research.
Current Opinion in HIV and AIDS.
8:572-578.
2013
|
|
| 2013
|
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
BMJ Open.
3:927-935.
2013
|
|
| 2013
|
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
Journal of Infectious Diseases.
208:1240-1249.
2013
|
|
| 2013
|
A pilot study of Screening, Brief Intervention, and Referral for Treatment (SBIRT) in non-treatment seeking smokers with HIV.
Addictive Behaviors.
38:2541-2546.
2013
|
|
| 2013
|
Physical activity and health outcomes among HIV-infected men who have sex with men: A longitudinal mediational analysis.
Annals of Behavioral Medicine.
46:149-156.
2013
|
|
| 2013
|
Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric Co-morbidities Who show significant response to treatment.
AIDS and Behavior.
17:2781-2791.
2013
|
|
| 2013
|
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
Clinical Infectious Diseases.
57:756-764.
2013
|
|
| 2013
|
Characteristics of an ambulatory palliative care clinic for HIV-infected patients.
Journal of Palliative Medicine.
16:934-937.
2013
|
|
| 2013
|
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis.
PLoS One.
8.
2013
|
|
| 2013
|
Impact of a computer-assisted, provider-delivered intervention on sexual risk behaviors in HIV-positive men who have sex with men (MSM) in a primary care setting
2013
|
|
| 2013
|
When to start antiretroviral therapy: As soon as possible.
BMC Medicine.
11.
2013
|
|
| 2013
|
Short communication: Lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States.
AIDS Research and Human Retroviruses.
29:887-891.
2013
|
|
| 2013
|
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: Final 5-year results from STARTMRK
2013
|
|
| 2013
|
Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomes.
AIDS Research and Human Retroviruses.
29:698-703.
2013
|
|
| 2013
|
Invasive cervical cancer risk among HIV-infected women: A North American multicohort collaboration prospective study
2013
|
|
| 2013
|
The role of palliative care in the current HIV treatment era in developed countries.
Topics in antiviral medicine.
21:20-26.
2013
|
|
| 2013
|
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV.
AIDS and Behavior.
17:307-318.
2013
|
|
| 2013
|
Maraviroc observational study: The impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced patients.
AIDS Research and Human Retroviruses.
29:105-111.
2013
|
|
| 2013
|
Measurement of the ZZ production cross section and search for anomalous couplings in 2ℓ2ℓ′ final states in pp collisions at s=7 TeV
2013
|
|
| 2013
|
Pain is independently associated with impaired physical function in HIV-infected patients.
Pain Medicine.
14:1985-1993.
2013
|
|
| 2012
|
Multimorbidity patterns in HIV-infected patients: The role of obesity in chronic disease clustering
2012
|
|
| 2012
|
HIV infection and obesity: Where did all the wasting go?.
Antiviral Therapy.
17:1281-1289.
2012
|
|
| 2012
|
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: Relation with patient and cohort characteristics.
International Journal of Epidemiology.
41:1807-1820.
2012
|
|
| 2012
|
New and investigational antiretroviral drugs for HIV infection: Mechanisms of action and early research findings.
Topics in antiviral medicine.
20:162-167.
2012
|
|
| 2012
|
Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.
Clinical Infectious Diseases.
55:1550-1557.
2012
|
|
| 2012
|
Editorial commentary: Viva no différence!.
Clinical Infectious Diseases.
55:1252-1254.
2012
|
|
| 2012
|
Linezolid for treatment of chronic extensively drug-resistant tuberculosis..
New England Journal of Medicine.
367:1508-1518.
2012
|
|
| 2012
|
Pain, mood, and substance abuse in HIV: Implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure
2012
|
|
| 2012
|
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials.
Journal of Antimicrobial Chemotherapy.
67:2020-2028.
2012
|
|
| 2012
|
Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing.
PLoS Pathogens.
8.
2012
|
|
| 2012
|
Biomarkers to monitor safety in people on art and risk of mortality.
2012
|
|
| 2012
|
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: Pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials
2012
|
|
| 2012
|
Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: A cohort study.
International Journal of Epidemiology.
41:448-459.
2012
|
|
| 2012
|
Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: A retrospective application of prediction-based classification.
PLoS Medicine.
9.
2012
|
|
| 2012
|
The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: Collaborative cohort analysis.
HIV Medicine.
13:89-97.
2012
|
|
| 2012
|
A search for a doubly-charged Higgs boson in pp collisions at √s=7 TeV
2012
|
|
| 2012
|
Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention
2012
|
|
| 2012
|
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: Week-192 overall and subgroup analyses from STARTMRK.
HIV Clinical Trials.
13:228-232.
2012
|
|
| 2012
|
Patient reported outcomes in routine care: Advancing data capture for HIV cohort research.
Clinical Infectious Diseases.
54:141-147.
2012
|
|
| 2012
|
Search for exclusive or semi-exclusive γ γ production and observation of exclusive and semi-exclusive e+e- production in pp collisions at √ s = 7 TeV
2012
|
|
| 2011
|
HIV now firmly established in the middle ages.
Clinical Infectious Diseases.
53:1140-1142.
2011
|
|
| 2011
|
Health-related quality of life in the gender, race, and clinical experience trial.
AIDS Research and Treatment.
2011.
2011
|
|
| 2011
|
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study
2011
|
|
| 2011
|
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Clinical Infectious Diseases.
53:927-935.
2011
|
|
| 2011
|
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.
Clinical Infectious Diseases.
53:807-816.
2011
|
|
| 2011
|
Recurrent signature patterns in hiv-1 b clade envelope glycoproteins associated with either early or chronic infections.
PLoS Pathogens.
7.
2011
|
|
| 2011
|
The role of toxicity-related regimen changes in the development of antiretroviral resistance.
AIDS Research and Human Retroviruses.
27:957-963.
2011
|
|
| 2011
|
Temporal Trends in presentation for outpatient HIV Medical Care 2000-2010: Implications for short-term mortality.
Journal of General Internal Medicine.
26:745-750.
2011
|
|
| 2011
|
Transmitted drug resistance in the CFAR network of integrated clinical systems Cohort: Prevalence and effects on pre-therapy CD4 and viral load.
PLoS One.
6.
2011
|
|
| 2011
|
Underutilization of the AIDS drug assistance program: Associated factors and policy implications.
Health Services Research.
46:982-995.
2011
|
|
| 2011
|
Age at cancer diagnosis among persons with AIDS..
Annals of Internal Medicine.
154:642-643.
2011
|
|
| 2011
|
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
AIDS.
25:691-700.
2011
|
|
| 2011
|
The ghosts of Christmas past. How would those we've lost guide us today?.
Positively aware : the monthly journal of the Test Positive Aware Network.
23:10-12.
2011
|
|
| 2011
|
Comparative effectiveness and toxicity of statins among HIV-infected patients.
Clinical Infectious Diseases.
52:387-395.
2011
|
|
| 2011
|
Erratum: Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects (Clinical Pharmacology and Therapeutics (1995) 58 (44-53) DOI: 10.1016/0009-9236(95)90071-3).
Clinical Pharmacology and Therapeutics.
89:320.
2011
|
|
| 2011
|
Health care system and policy factors influencing engagement in HIV medical care: Piecing together the fragments of a fractured health care delivery system.
Clinical Infectious Diseases.
52.
2011
|
|
| 2011
|
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.
AIDS.
25:185-195.
2011
|
|
| 2011
|
Aging With HIV: A Cross-Sectional Study of Comorbidity Prevalence and Clinical Characteristics Across Decades of Life.
Journal of the Association of Nurses in AIDS Care.
22:17-25.
2011
|
|
| 2011
|
Dependence on pseudorapidity and on centrality of charged hadron production in PbPb collisions at √sNN = 2.76 TeV
2011
|
|
| 2011
|
Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men.
Pharmacogenetics and Genomics.
21:798-807.
2011
|
|
| 2011
|
Measurement of the inclusive Z cross section via decays to tau pairs in pp collisions at √s = 7 TeV
2011
|
|
| 2011
|
Measurement of the tt production cross section and the top quark mass in the dilepton channel in pp collisions at √s = 7 TeV: The CMS collaboration
2011
|
|
| 2011
|
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
2011
|
|
| 2011
|
Search for large extra dimensions in the diphoton final state at the Large Hadron Collider
2011
|
|
| 2011
|
Search for physics beyond the standard model in opposite-sign dilepton events in pp collisions at √s = 7 TeV
2011
|
|
| 2011
|
To the Editor.
ACP journal club.
154:642-643.
2011
|
|
| 2010
|
CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?.
AIDS Research and Therapy.
7.
2010
|
|
| 2010
|
Darunavir outcomes study: Comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks.
AIDS Research and Human Retroviruses.
26:1279-1285.
2010
|
|
| 2010
|
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.
American Journal of Kidney Diseases.
56:872-882.
2010
|
|
| 2010
|
Virologic and immunologic response to HAART, by age and regimen class.
AIDS.
24:2469-2479.
2010
|
|
| 2010
|
Letter in response to the new SHEA guideline for healthcare workers with hepatitis B Virus, hepatitis C virus, and/or human immunodeficiency virus.
Infection Control and Hospital Epidemiology.
31:1092-1093.
2010
|
|
| 2010
|
Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.
Antimicrobial Agents and Chemotherapy.
54:4137-4142.
2010
|
|
| 2010
|
Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.
Clinical Infectious Diseases.
51:718-724.
2010
|
|
| 2010
|
Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction.
Journal of Virology.
84:8712-8720.
2010
|
|
| 2010
|
Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the roche COBAS ampliprep/COBAS TaqMan HIV-1 Version 1.0 viral load test
2010
|
|
| 2010
|
Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.
HIV Medicine.
11:462-468.
2010
|
|
| 2010
|
Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.
AIDS.
24:1717-1726.
2010
|
|
| 2010
|
How do HIV elite controllers do what they do?.
Clinical Infectious Diseases.
51:239-241.
2010
|
|
| 2010
|
Erratum: Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174 (AIDS Research and Human Retroviruses (2010) 26 (425-432)).
AIDS Research and Human Retroviruses.
26:839.
2010
|
|
| 2010
|
Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9)
2010
|
|
| 2010
|
Late presentation for human immunodeficiency virus care in the United States and Canada.
Clinical Infectious Diseases.
50:1512-1520.
2010
|
|
| 2010
|
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
Journal of Infectious Diseases.
201:1481-1487.
2010
|
|
| 2010
|
Causes of death in HIV-1-Infected patients treated with antiretroviral therapy, 1996-2006: Collaborative analysis of 13 HIV cohort studies.
Clinical Infectious Diseases.
50:1387-1396.
2010
|
|
| 2010
|
Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting.
Clinical Infectious Diseases.
50:1165-1173.
2010
|
|
| 2010
|
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: Results of ACTG A5174.
AIDS Research and Human Retroviruses.
26:425-432.
2010
|
|
| 2010
|
A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: Study design, implementation, and baseline cohort characteristics.
PLoS One.
5.
2010
|
|
| 2010
|
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
Journal of Infectious Diseases.
201:803-813.
2010
|
|
| 2010
|
Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care.
Clinical Infectious Diseases.
50:574-584.
2010
|
|
| 2010
|
Antiretroviral prescribing patterns in treatment-naïve patients in the United States
2010
|
|
| 2010
|
Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing
2010
|
|
| 2010
|
Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.
American Journal of Epidemiology.
171:198-205.
2010
|
|
| 2010
|
Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT study.
HIV Clinical Trials.
11:125-132.
2010
|
|
| 2009
|
Modeling sequence evolution in acute HIV-1 infection.
Journal of Theoretical Biology.
261:341-360.
2009
|
|
| 2009
|
Gender differences in discontinuation of antiretroviral treatment regimens
2009
|
|
| 2009
|
Novel drug classes: Entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists].
Current Opinion in HIV and AIDS.
4:513-517.
2009
|
|
| 2009
|
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Clinical Infectious Diseases.
49:1582-1590.
2009
|
|
| 2009
|
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements..
AIDS.
23:2199-2208.
2009
|
|
| 2009
|
Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study.
AIDS.
23:1539-1546.
2009
|
|
| 2009
|
Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.
International Journal of Epidemiology.
38:746-756.
2009
|
|
| 2009
|
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.
Journal of Experimental Medicine.
206:1273-1289.
2009
|
|
| 2009
|
A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1.
Journal of Infectious Diseases.
199:1638-1647.
2009
|
|
| 2009
|
HIV policy: The path forward- A joint position paper of the HIV medicine association of the infectious diseases society of America and the American College of physicians.
Clinical Infectious Diseases.
48:1335-1344.
2009
|
|
| 2009
|
Editorial: Ryan white: An unintentional home builder.
The AIDS reader.
19:166-168.
2009
|
|
| 2009
|
Ryan White: an unintentional home builder..
The AIDS reader.
19:166-168.
2009
|
|
| 2009
|
Effect of early versus deferred antiretroviral therapy for HIV on survival.
New England Journal of Medicine.
360:1815-1826.
2009
|
|
| 2009
|
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal.
Clinical Infectious Diseases.
48:1138-1151.
2009
|
|
| 2009
|
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.
Clinical Infectious Diseases.
48:787-794.
2009
|
|
| 2009
|
Missed visits and mortality among patients establishing initial outpatient HIV treatment.
Clinical Infectious Diseases.
48:248-256.
2009
|
|
| 2009
|
Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients.
Journal of Clinical Epidemiology.
62.
2009
|
|
| 2009
|
HIV/AIDS: The only thing constant....
Journal of the National Medical Association.
101:1299-1300.
2009
|
|
| 2009
|
Racial disparities in HIV virologic failure: Do missed visits matter?
2009
|
|
| 2009
|
The therapeutic implications of timely linkage and early retention in HIV care
2009
|
|
| 2008
|
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: Collaborative analysis of prospective cohort studies.
Antiviral Therapy.
13:959-967.
2008
|
|
| 2008
|
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
Journal of Infectious Diseases.
198:1345-1352.
2008
|
|
| 2008
|
Short-term discontinuation of HAART regimens more common in vulnerable patient populations.
AIDS Research and Human Retroviruses.
24:1347-1355.
2008
|
|
| 2008
|
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.
AIDS.
22:1951-1960.
2008
|
|
| 2008
|
Cohort profile: The centers for AIDS research network of integrated clinical systems.
International Journal of Epidemiology.
37:948-955.
2008
|
|
| 2008
|
Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection.
New England Journal of Medicine.
359:1442-1455.
2008
|
|
| 2008
|
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.
AIDS.
22:1821-1827.
2008
|
|
| 2008
|
Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy.
AIDS Research and Human Retroviruses.
24:1031-1035.
2008
|
|
| 2008
|
An open-label safety study of enfuvirtide injection with a needle-free injection device or needle/syringe: The Biojector 2000 open-label safety study (BOSS).
AIDS Research and Human Retroviruses.
24:805-813.
2008
|
|
| 2008
|
Gastrointestinal complications of HIV infection: Changing priorities in the HAART era.
Gut.
57:861-870.
2008
|
|
| 2008
|
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
2008
|
|
| 2008
|
Treatment response in acute/early infection versus advanced AIDS: Equivalent first and second phases of HIV RNA decline.
AIDS.
22:957-962.
2008
|
|
| 2008
|
Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV Clinic.
Clinical Infectious Diseases.
46:1315-1318.
2008
|
|
| 2008
|
AIDS therapy, third edition.
The AIDS reader.
18.
2008
|
|
| 2008
|
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy
2008
|
|
| 2008
|
High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
Clinical Infectious Diseases.
46:1111-1118.
2008
|
|
| 2008
|
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
Journal of Interferon and Cytokine Research.
28:89-100.
2008
|
|
| 2007
|
Opt-out testing: Who can afford to take care of patients with newly diagnosed HIV infection?.
Clinical Infectious Diseases.
45.
2007
|
|
| 2007
|
HIV discrimination and the health of women living with HIV
2007
|
|
| 2007
|
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients
2007
|
|
| 2007
|
Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era.
Clinical Infectious Diseases.
45:658-661.
2007
|
|
| 2007
|
Failure to establish HIV care: Characterizing the "no show" phenomenon.
Clinical Infectious Diseases.
45:127-130.
2007
|
|
| 2007
|
CMS physics technical design report, volume II: Physics performance.
Journal of Physics G: Nuclear and Particle Physics.
34:995-1579.
2007
|
|
| 2007
|
HIV care at a crossroads: The emerging crisis in the US HIV epidemic.
Medscape journal of medicine.
9.
2007
|
|
| 2007
|
Cohort profile: The North American AIDS cohort collaboration on research and design (NA-ACCORD).
International Journal of Epidemiology.
36:294-301.
2007
|
|
| 2007
|
Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings
2007
|
|
| 2007
|
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists.
Arthritis and Rheumatism.
56:1125-1133.
2007
|
|
| 2007
|
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients.
AIDS.
21.
2007
|
|
| 2007
|
Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?.
Clinical Infectious Diseases.
44:135-138.
2007
|
|
| 2006
|
Which policy to ADAP-T: Waiting lists or waiting lines?.
Clinical Infectious Diseases.
43:1365-1367.
2006
|
|
| 2006
|
A plea for justice for jailed medical workers [4].
Science.
314:924-925.
2006
|
|
| 2006
|
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum.
2006
|
|
| 2006
|
Ryan White Care Act reauthorization: We need help.
The AIDS reader.
16:594-596.
2006
|
|
| 2006
|
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: The results of AIDS Clinical Trials Group 5068.
Journal of Infectious Diseases.
194:623-632.
2006
|
|
| 2006
|
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes.
Journal of the American Medical Association.
296:782-793.
2006
|
|
| 2006
|
Treatment for adult HIV infection: 2006 Recommendations of the International AIDS Society-USA panel.
Journal of the American Medical Association.
296:827-843.
2006
|
|
| 2006
|
The experts speak. Burn-out among HIV care providers. Interview by Vicki Glaser.
2006
|
|
| 2006
|
Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patient.
Journal of the International AIDS Society.
8.
2006
|
|
| 2006
|
Distribution of health care expenditures for HIV-infected patients.
Clinical Infectious Diseases.
42:1003-1010.
2006
|
|
| 2006
|
Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials.
Clinical Infectious Diseases.
42:870-877.
2006
|
|
| 2006
|
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.
AIDS Research and Human Retroviruses.
22:232-239.
2006
|
|
| 2006
|
Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy.
AIDS Research and Human Retroviruses.
22:125-131.
2006
|
|
| 2006
|
Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.
Clinical Infectious Diseases.
42:126-131.
2006
|
|
| 2006
|
Roundtable. Who should be providing HIV care?.
AIDS clinical care.
18:21-24.
2006
|
|
| 2006
|
Ryan White CARE Act reauthorization: we need help..
Topics in antiviral medicine.
14:93-94.
2006
|
|
| 2006
|
Sustained HIV viral suppression following treatment interruption: An observational study.
AIDS Research and Human Retroviruses.
22:40-44.
2006
|
|
| 2006
|
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel..
Topics in antiviral medicine.
14:827-843.
2006
|
|
| 2005
|
Confirmation of the doubly charmed baryon Ξcc+(3520) via its decay to pD+K-
2005
|
|
| 2005
|
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Nature Medicine.
11:1170-1172.
2005
|
|
| 2005
|
Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature.
AIDS Research and Human Retroviruses.
21:753-756.
2005
|
|
| 2005
|
Antigenic conservation and immunogenicity of the HIV coreceptor binding site.
Journal of Experimental Medicine.
201:1407-1419.
2005
|
|
| 2005
|
Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care.
Sexually Transmitted Diseases.
32:20-26.
2005
|
|
| 2004
|
Observation of a narrow charm-strange meson D sJ+(2632) → D s+η and D 0K +.
Physical Review Letters.
93.
2004
|
|
| 2004
|
Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
Journal of Experimental Medicine.
200:1243-1256.
2004
|
|
| 2004
|
Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients.
AIDS Research and Human Retroviruses.
20:1037-1045.
2004
|
|
| 2004
|
Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.
Clinical Infectious Diseases.
39:1380-1384.
2004
|
|
| 2004
|
Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: A randomized trial.
Journal of the American Medical Association.
292:180-190.
2004
|
|
| 2004
|
Treatment for adult HIV infection: 2004 Recommendations of the international AIDS society-USA panel.
Journal of the American Medical Association.
292:251-265.
2004
|
|
| 2004
|
Upper limit on the decay Σ(1385)-→Σ -γ and cross section for γΣ -→Λπ-
2004
|
|
| 2004
|
Anemia in HIV infection: Clinical impact and evidence-based management strategies.
Clinical Infectious Diseases.
38:1454-1463.
2004
|
|
| 2004
|
Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients
2004
|
|
| 2004
|
A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program.
2004
|
|
| 2004
|
Initiation of antiretroviral therapy: implications of recent findings..
Topics in antiviral medicine.
12:83-88.
2004
|
|
| 2003
|
HIV Protease Inhibitor Ritonavir Induces Lipoatrophy in Male Mice.
AIDS Research and Human Retroviruses.
19:1141-1150.
2003
|
|
| 2003
|
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.
HIV Clinical Trials.
4:287-300.
2003
|
|
| 2003
|
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
Journal of Infectious Diseases.
188:625-634.
2003
|
|
| 2003
|
Duration of highly active antiretroviral therapy regimens.
Clinical Infectious Diseases.
37:714-722.
2003
|
|
| 2003
|
Is It Time to Proactively Switch Successful Antiretroviral Therapy? Carefully Check Your SWATCH.
ACP journal club.
139:148-149.
2003
|
|
| 2003
|
Erratum: Antibody neutralization and escape by HIV-1 (Nature (2003) 422 (307-312)).
Nature.
423:197.
2003
|
|
| 2003
|
Production asymmetry of Ds from 600 GeV/c σ- and π- beam
2003
|
|
| 2003
|
Antibody neutralization and escape by HIV-1.
Nature.
422:307-312.
2003
|
|
| 2003
|
Antiretroviral therapy: select lessons from recent studies..
Topics in antiviral medicine.
11:164-168.
2003
|
|
| 2002
|
Enfuvirtide.
Expert Opinion on Investigational Drugs.
11:1837-1843.
2002
|
|
| 2002
|
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
2002
|
|
| 2002
|
Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.
AIDS Research and Human Retroviruses.
18:909-916.
2002
|
|
| 2002
|
Patient-perceived barriers to antiretroviral adherence: Associations with race
2002
|
|
| 2002
|
First observation of the doubly charmed baryon Ξcc+.
Physical Review Letters.
89.
2002
|
|
| 2002
|
Durability of response to treatment among antiretroviral-experienced subjects: 48-Week results from AIDS Clinical Trials Group Protocol 359.
Journal of Infectious Diseases.
186:626-633.
2002
|
|
| 2002
|
First measurement of π-e→π-eγ pion virtual compton scattering.
Physical Review C.
66:346131-346139.
2002
|
|
| 2002
|
Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel.
Journal of the American Medical Association.
288:222-235.
2002
|
|
| 2002
|
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
Antimicrobial Agents and Chemotherapy.
46:1896-1905.
2002
|
|
| 2002
|
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.
AIDS.
16:579-588.
2002
|
|
| 2002
|
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.
International Journal of Epidemiology.
31:951-958.
2002
|
|
| 2002
|
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.
AIDS Research and Human Retroviruses.
18:685-693.
2002
|
|
| 2001
|
Measurement of the Ds± lifetime
2001
|
|
| 2001
|
Measurement of the σ- charge radius by σ--electron elastic scattering
2001
|
|
| 2001
|
Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases.
Clinical Infectious Diseases.
33:1914-1921.
2001
|
|
| 2001
|
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).
AIDS.
15:1971-1978.
2001
|
|
| 2001
|
Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.
AIDS Research and Human Retroviruses.
17:1379-1385.
2001
|
|
| 2001
|
Toward a definition of HIV expertise: A survey of experienced HIV physicians
2001
|
|
| 2001
|
Precision measurements of the ∧c+ and D0 lifetimes.
Physical Review Letters.
86:5243-5246.
2001
|
|
| 2001
|
HIV resistance testing in clinical practice: A QALY-fied success.
ACP journal club.
134:475-477.
2001
|
|
| 2001
|
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 env, gag, and pro in combination with RGP120.
Journal of Infectious Diseases.
183:563-570.
2001
|
|
| 2001
|
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.
Journal of Infectious Diseases.
183:401-408.
2001
|
|
| 2000
|
Health-related quality of life and virologic outcomes in an HIV clinic.
Quality of Life Research.
9:977-985.
2000
|
|
| 2000
|
The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3.
American Journal of Gastroenterology.
95:3142-3146.
2000
|
|
| 2000
|
The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3..
American Journal of Gastroenterology.
95:3142-3146.
2000
|
|
| 2000
|
Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults.
Antimicrobial Agents and Chemotherapy.
44:2672-2678.
2000
|
|
| 2000
|
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
ACP journal club.
133.
2000
|
|
| 2000
|
Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis.
AIDS Research and Human Retroviruses.
16:1123-1133.
2000
|
|
| 2000
|
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis.
Clinical Infectious Diseases.
30:47-54.
2000
|
|
| 2000
|
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA panel.
Journal of the American Medical Association.
283:381-390.
2000
|
|
| 2000
|
Practice guidelines for the management of cryptococcal disease.
Clinical Infectious Diseases.
30:710-718.
2000
|
|
| 2000
|
Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.
Clinical Infectious Diseases.
31:1095-1097.
2000
|
|
| 2000
|
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.
Clinical Infectious Diseases.
30:749-756.
2000
|
|
| 1999
|
Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
Journal of Infectious Diseases.
180:1851-1862.
1999
|
|
| 1999
|
Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy.
AIDS.
13:1677-1685.
1999
|
|
| 1999
|
Predictors of optimal virological response to potent antiretroviral therapy.
AIDS.
13:1873-1880.
1999
|
|
| 1999
|
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
AIDS Research and Human Retroviruses.
15:1413-1417.
1999
|
|
| 1999
|
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
Enfermedades Infecciosas y Microbiologia.
19:213-214.
1999
|
|
| 1999
|
Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.
Journal of Infectious Diseases.
180:847-849.
1999
|
|
| 1999
|
Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals.
AIDS Research and Human Retroviruses.
15:1063-1071.
1999
|
|
| 1999
|
HIV-1 and HAART: A time to cure, a time to kill.
Nature Medicine.
5:609-611.
1999
|
|
| 1999
|
Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.
Journal of Experimental Medicine.
189:1545-1554.
1999
|
|
| 1999
|
A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US
1999
|
|
| 1999
|
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group..
Clinical Infectious Diseases.
28:291-296.
1999
|
|
| 1999
|
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
Clinical Infectious Diseases.
28:291-298.
1999
|
|
| 1999
|
Antiretrovirals for HIV nephropathy?.
AIDS clinical care.
11:50.
1999
|
|
| 1999
|
Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
Journal of Clinical Investigation.
103:1391-1398.
1999
|
|
| 1998
|
Antiretroviral chemotherapy.
Current clinical topics in infectious diseases.
154-179.
1998
|
|
| 1998
|
Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults.
AIDS.
12.
1998
|
|
| 1998
|
Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team..
AIDS.
12:F203-F209.
1998
|
|
| 1998
|
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
Nature Medicine.
4:1302-1307.
1998
|
|
| 1998
|
Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS.
Immunopharmacology.
40:91-103.
1998
|
|
| 1998
|
Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA panel.
Journal of the American Medical Association.
280:78-86.
1998
|
|
| 1998
|
The changing face of AIDS research and human retroviruses: A new forum to display your ART-work.
AIDS Research and Human Retroviruses.
14:721.
1998
|
|
| 1998
|
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: A meta-analysis of randomized individual patient data.
Journal of Infectious Diseases.
178:349-359.
1998
|
|
| 1998
|
Faculty roundtable discussion
1998
|
|
| 1998
|
Report of the NIH panel to define principles of therapy of HIV infection.
ACP journal club.
128:1057-1078.
1998
|
|
| 1998
|
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.
Journal of Infectious Diseases.
177:40-47.
1998
|
|
| 1997
|
Long term virological and immunological effect of the HIV protease inhibitor, VIRACEPT® (nelfinavir mesylate, NFV) in combination with zidovudine (AZT) and lamivudine (3TC).
Clinical Infectious Diseases.
25:396.
1997
|
|
| 1997
|
Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-α2a in patients with HIV
1997
|
|
| 1997
|
Effects of tapering doses of oral prednisone on viral load among HIV- infected patients with unexplained weight loss.
AIDS Research and Human Retroviruses.
13:1533-1537.
1997
|
|
| 1997
|
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome.
American Journal of Medicine.
103:223-232.
1997
|
|
| 1997
|
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.
New England Journal of Medicine.
337:15-21.
1997
|
|
| 1997
|
Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society-USA panel.
Journal of the American Medical Association.
277:1962-1969.
1997
|
|
| 1997
|
Candidate antiretroviral agents for use in postexposure prophylaxis..
American Journal of Medicine.
102:25-31.
1997
|
|
| 1997
|
Itraconazole oral solution: Pharmacokinetics and absorption
1997
|
|
| 1997
|
The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS.
Quality of Life Research.
6:3-10.
1997
|
|
| 1997
|
Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain- triglyceride-containing formula.
Journal of the Academy of Nutrition and Dietetics.
97:605-611.
1997
|
|
| 1997
|
Dermatologic manifestations of human immunodeficiency virus infection.
Current Problems in Dermatology -Chicago then St Louis-.
9:205-242.
1997
|
|
| 1997
|
Erratum: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome (New England Journal of Medicine (1997) 337 (15-21)).
New England Journal of Medicine.
337:1557-1558.
1997
|
|
| 1997
|
Use of HIV viral load in clinical practice: Back to the future.
ACP journal club.
126:983-985.
1997
|
|
| 1996
|
Treatment of HIV-1 infection: An overview of new strategies and novel agents.
Infections in medicine.
13:903-911.
1996
|
|
| 1996
|
HIV viral load markers in clinical practice.
Nature Medicine.
2:625-629.
1996
|
|
| 1996
|
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
1996
|
|
| 1996
|
Antiretroviral Therapy for HIV Infection in 1996 Recommendations of an International Panel.
Journal of the American Medical Association.
276:146-154.
1996
|
|
| 1996
|
Clinical experience with non-nucleoside reverse transcreptase inhibitors: L-697,661 and nevirapine.
Advances in Experimental Medicine and Biology.
394:291-298.
1996
|
|
| 1996
|
HIV-specific cellular and humoral immune responses in primary HIV infection.
AIDS Research and Human Retroviruses.
12:1129-1140.
1996
|
|
| 1996
|
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection a randomized, double-blind, placebo-controlled trial.
ACP journal club.
124:1019-1030.
1996
|
|
| 1996
|
To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour..
AIDS clinical care.
8:1-4.
1996
|
|
| 1995
|
A preliminary study of ritonavir, an inhibitor of hiv-1 protease, to treat hiv-1 infection.
New England Journal of Medicine.
333:1534-1540.
1995
|
|
| 1995
|
Clinical evaluation of the safety and efficacy of ritonavir (ABT-538), an inhibitor of HIV-1 protease.
Medecine Biologie Environnement.
23:257-265.
1995
|
|
| 1995
|
Viral dynamics in human immunodeficiency virus type 1 infection.
Nature.
373:117-122.
1995
|
|
| 1995
|
An approach to antiretroviral treatment of HIV disease. The situation: an overview..
Hospital practice (1995).
30 Suppl 1:3-4.
1995
|
|
| 1995
|
Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared
1995
|
|
| 1995
|
Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma.
AIDS Research and Human Retroviruses.
11:353-361.
1995
|
|
| 1995
|
Editorialresponse: Clinical and host differences between infections with the two varieties of cryptococcus neoformans.
Clinical Infectious Diseases.
21:35-36.
1995
|
|
| 1995
|
Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects.
Clinical Pharmacology and Therapeutics.
58:44-53.
1995
|
|
| 1995
|
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations.
Clinical Infectious Diseases.
21.
1995
|
|
| 1994
|
Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?.
Infectious agents and disease.
3:313-323.
1994
|
|
| 1994
|
What to do when zidovudine fails.
New England Journal of Medicine.
330:706-707.
1994
|
|
| 1994
|
Evolving Understanding of the Immunopathogenesis of HIV.
AIDS Research and Human Retroviruses.
10:887-892.
1994
|
|
| 1994
|
HIV-1 Sequence Subtype D in the United States.
AIDS Research and Human Retroviruses.
10:625-627.
1994
|
|
| 1994
|
Human immunodeficiency virus infection.
Clinical Infectious Diseases.
18:963-973.
1994
|
|
| 1994
|
Issues in combination antiretroviral therapy: A review
1994
|
|
| 1994
|
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV.
Nature.
370:463-467.
1994
|
|
| 1994
|
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of aids-associated cryptococcal meningitis.
Clinical Infectious Diseases.
18:789-792.
1994
|
|
| 1994
|
Pathogenicity and diversity of hiv and implications for clinical management: A review
1994
|
|
| 1993
|
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.
New England Journal of Medicine.
329:1065-1072.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection
1993
|
|
| 1993
|
A Molecular Clone of HIV-1 Tropic and Cytopathic for Human and Chimpanzee Lymphocytes.
Virology.
194:858-864.
1993
|
|
| 1993
|
Cryptococcal meningitis in AIDS.
Hospital practice (1995).
28.
1993
|
|
| 1993
|
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
AIDS.
7.
1993
|
|
| 1993
|
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
Science.
259:1749-1754.
1993
|
|
| 1993
|
In Vitro Effect of Ofloxacin Alone and in Combination with Ceftazidime or Gentamicin against P. aeruginosa.
Drugs.
45:234-235.
1993
|
|
| 1993
|
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection
1993
|
|
| 1993
|
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
ACP journal club.
118:610-616.
1993
|
|
| 1993
|
Response [2].
Science.
260:1705-1706.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection [21]
1993
|
|
| 1992
|
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group..
New England Journal of Medicine.
326:793-798.
1992
|
|
| 1992
|
A controlled trial of fluconazole or amphotericin b to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
New England Journal of Medicine.
326:793-798.
1992
|
|
| 1992
|
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group..
New England Journal of Medicine.
326:83-89.
1992
|
|
| 1992
|
Comparison of amphotericin b with fluconazole in the treatment of acute aids-associated cryptococcal meningitis.
New England Journal of Medicine.
326:83-89.
1992
|
|
| 1992
|
Adverse effects.
Hospital practice (Office ed.).
27:26-36.
1992
|
|
| 1992
|
Itraconazole therapy for blastomycosis and histoplasmosis.
American Journal of Medicine.
93:489-497.
1992
|
|
| 1991
|
Primary hiv-1 infection.
New England Journal of Medicine.
325:733-735.
1991
|
|
| 1991
|
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
New England Journal of Medicine.
324:954-960.
1991
|
|
| 1991
|
Aerosol pentamidine prophylaxis following pneumocystis carinii pneumonia in AIDS patients: Results of a blinded dose-comparison study using an ultrasonic nebulizer.
American Journal of Medicine.
90:418-426.
1991
|
|
| 1991
|
High-level viremia in adults and children infected with human immunodeficiency virus: Relation to disease stage and cd4+lymphocyte levels.
Journal of Infectious Diseases.
164:72-80.
1991
|
|
| 1991
|
United parkinson foundation neurotransplantation registry on adrenal medullary transplants: Presurgical, and 1– and 2–year follow–up.
Neurology.
41:1719-1722.
1991
|
|
| 1990
|
The newer antifungal agents.
Infections in medicine.
7:4-8+32.
1990
|
|
| 1988
|
Individuals infected with HIV possess antibodies against IL-2.
Immunology.
65:611-615.
1988
|
|
| 1988
|
Azole antifungal agents: Emphasis on new triazoles.
Antimicrobial Agents and Chemotherapy.
32:1-8.
1988
|
|
| 1988
|
Biologically diverse molecular variants within a single HIV-1 isolate.
Nature.
334:444-447.
1988
|
|
| 1988
|
Extensive variation of human immunodeficiency virus type-1 in vivo.
Nature.
334:440-444.
1988
|
|
| 1988
|
Treatment of histoplasmosis and blastomycosis.
Chest.
93:848-851.
1988
|
|
| 1987
|
Brief report: In vitro activity of ciprofloxacin against Neisseria gonorrhoeae.
American Journal of Medicine.
82:40-41.
1987
|
|
| 1987
|
The infectious etiology of chronic rheumatic diseases.
Seminars in Arthritis and Rheumatism.
17:1-23.
1987
|
|
| 1986
|
Q fever endocarditis..
American Journal of the Medical Sciences.
292:104-106.
1986
|
|
| 1986
|
Asymptomatic Blood Donor with a False Positive HTLV-III Western Blot.
New England Journal of Medicine.
314:118.
1986
|
|
| 1986
|
Case report: Q fever endocarditis.
American Journal of the Medical Sciences.
292:104-106.
1986
|
|
| 1986
|
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy.
30:25-30.
1986
|
|
| 1985
|
Approach to the use of antimicrobial combinations..
The Alabama journal of medical sciences.
22:72-75.
1985
|
|
| 1981
|
Surgical determination of the site of crossing of jaw-opening reflex evoked by tooth pulp stimulation in the cat.
Brain Research.
212:140-144.
1981
|
|
| 1980
|
Clinical approach to the choice of antimicrobial therapy, case #22: Recurrent furunculosis.
The Journal of the Kentucky Medical Association.
78:722-725.
1980
|
|
